Key facts
- Nevoa’s last known valuation is $22.9M (Jan 2025).
- It has raised $16.4M; the latest was Later Stage VC ($5.9M) in Jan 2025.
- Notable investors include Singularity Capital, BCG Digital Ventures.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Nevoa
- ·The full record, as it builds
Funding rounds
No funding rounds for Nevoa are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Nevoa
Developer of a hospital-grade surface disinfecting system designed to atomize EPA-registered hypochlorous acid. The company's system includes an automated disinfection robot designed specifically to be used every time a new patient checks in hospital rooms to eradicate pathogens, enabling healthcare institutions to have an environmentally responsible disinfecting system resulting in patients feeling confident about the pathogen-free facilities.
- Sector
- Healthcare
- HQ
- Gilbert, AZ, United States
- Founded
- 2009
- Employees
- 11
- Website
- nevoainc.com/
- Ownership
- Privately Held (backing)
Nevoa doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nevoa shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nevoa in its N-PORT filings yet. We sweep new filings monthly.